Shenzhen - Delayed Quote CNY

Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ)

5.23 -0.01 (-0.19%)
At close: April 26 at 3:04 PM GMT+8
Key Events
Loading Chart for 002412.SZ
DELL
  • Previous Close 5.24
  • Open 5.10
  • Bid 5.23 x --
  • Ask 5.24 x --
  • Day's Range 5.17 - 5.26
  • 52 Week Range 4.08 - 7.38
  • Volume 8,248,491
  • Avg. Volume 11,053,905
  • Market Cap (intraday) 2.632B
  • Beta (5Y Monthly) 0.33
  • PE Ratio (TTM) 18.03
  • EPS (TTM) 0.29
  • Earnings Date --
  • Forward Dividend & Yield 0.30 (5.74%)
  • Ex-Dividend Date Jun 20, 2023
  • 1y Target Est --

Hunan Hansen Pharmaceutical Co., Ltd. produces and sells traditional Chinese preparations in China and internationally. It provides medicines in injection, mixture, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. Hunan Hansen Pharmaceutical Co., Ltd. was founded in 1998 and is based in Yiyang, China.

www.hansenzy.com

1,533

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 002412.SZ

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

002412.SZ
22.86%
SSE Composite Index
3.82%

1-Year Return

002412.SZ
11.20%
SSE Composite Index
5.40%

3-Year Return

002412.SZ
4.86%
SSE Composite Index
11.10%

5-Year Return

002412.SZ
48.92%
SSE Composite Index
1.13%

Compare To: 002412.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 002412.SZ

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    2.63B

  • Enterprise Value

    2.50B

  • Trailing P/E

    17.87

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.86

  • Price/Book (mrq)

    1.41

  • Enterprise Value/Revenue

    2.72

  • Enterprise Value/EBITDA

    14.96

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    16.03%

  • Return on Assets (ttm)

    3.71%

  • Return on Equity (ttm)

    7.89%

  • Revenue (ttm)

    919.05M

  • Net Income Avi to Common (ttm)

    147.28M

  • Diluted EPS (ttm)

    0.29

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    225.72M

  • Total Debt/Equity (mrq)

    4.83%

  • Levered Free Cash Flow (ttm)

    6.7M

Company Insights: 002412.SZ

People Also Watch